Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

391 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility.
Pinto EM, Fridman C, Figueiredo BC, Salvador H, Teixeira MR, Pinto C, Pinheiro M, Kratz CP, Lavarino C, Legal EAMF, Le A, Kelly G, Koeppe E, Stoffel EM, Breen K, Hahner S, Heinze B, Techavichit P, Krause A, Ogata T, Fujisawa Y, Walsh MF, Rana HQ, Maxwell KN, Garber JE, Rodriguez-Galindo C, Ribeiro RC, Zambetti GP. Pinto EM, et al. HGG Adv. 2024 Jan 11;5(1):100244. doi: 10.1016/j.xhgg.2023.100244. Epub 2023 Oct 4. HGG Adv. 2024. PMID: 37794678 Free PMC article.
Clinical and immunophenotype correlating with response to immunotherapy in paediatric patients with primary liver carcinoma. A case series.
O'Neill AF, Church AJ, Feraco A, Spidle J, Wall CB, Kim HB, Elisofon S, Vakili K, Pimkin M, Dharia NV, Shelman NR, Perez-Atayde AR, Rodriguez-Galindo C. O'Neill AF, et al. Among authors: rodriguez galindo c. EBioMedicine. 2024 May 14;104:105147. doi: 10.1016/j.ebiom.2024.105147. Online ahead of print. EBioMedicine. 2024. PMID: 38749302 Free PMC article.
Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective.
Schultz KAP, Chintagumpala M, Piao J, Chen KS, Shah R, Gartrell RD, Christison-Lagay E, Pashnakar F, Berry JL, O'Neill AF, Vasta LM, Flynn A, Mitchell SG, Seynnaeve BK, Rosenblum J, Potter SL, Kamihara J, Rodriguez-Galindo C, Hawkins DS, Laetsch TW. Schultz KAP, et al. EJC Paediatr Oncol. 2023 Dec;2:100024. doi: 10.1016/j.ejcped.2023.100024. Epub 2023 Jul 20. EJC Paediatr Oncol. 2023. PMID: 37829670 Free PMC article.
Impact of a Regional Pediatric Hematology/Oncology Fellowship Program in Guatemala.
Moreira DC, Garrido C, Rosado R, Girón V, Letona T, Morales G, Valverde P, Velásquez T, Alfaro J, Orellana E, Ortega MA, Salguero P, Fox Irwin L, Andujar A, de Alarcón PA, Luna-Fineman S, Manco-Johnson M, Conter V, Verna M, Canesi M, Massimino M, Spreafico F, Ferrari A, Gassant PY, Vásquez R, Friedrich P, Mack R, Ribeiro R, Metzger ML, Rodriguez-Galindo C, Antillón-Klussmann F. Moreira DC, et al. Among authors: rodriguez galindo c. JCO Glob Oncol. 2024 Jun;10:e2300474. doi: 10.1200/GO.23.00474. JCO Glob Oncol. 2024. PMID: 38870436
The transformation of Cure4Kids: Expanding knowledge transfer capacity.
Berg F, Conger K, Avula M, Hansen C, Chatman G, Provasnik J, Alguire K, Wellman A, Chantada G, Rodriguez-Galindo C, Moreira DC. Berg F, et al. Among authors: rodriguez galindo c. Pediatr Blood Cancer. 2024 May 30:e31135. doi: 10.1002/pbc.31135. Online ahead of print. Pediatr Blood Cancer. 2024. PMID: 38814260
Unification of Efforts to Improve Global Access to Cancer Therapeutics: Report From the 2022/2023 Access to Essential Cancer Medicines Stakeholder Summit.
Briercheck E, Pyle D, Adams C, Atun R, Booth C, Dent J, Garcia-Gonzalez P, Ilbawi A, Jazieh AR, Kerr D, Knaul F, Kobayashi E, Lim C, Maza M, Milner D, Navarro MF, O'Brien M, Rodriguez-Galindo C, Sullivan R, Torode J, Vokes E, Gralow J. Briercheck E, et al. Among authors: rodriguez galindo c. JCO Glob Oncol. 2024 May;10:e2300256. doi: 10.1200/GO.23.00256. JCO Glob Oncol. 2024. PMID: 38781548
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures.
Bielamowicz K, Dimitrion P, Abla O, Bomken S, Campbell P, Collin M, Degar B, Diamond EL, Eckstein OS, El-Mallawany N, Fluchel M, Goyal G, Henry MM, Hermiston M, Hogarty M, Jeng M, Jubran R, Lubega J, Kumar A, Ladisch S, McClain KL, Merad M, Mi QS, Parsons DW, Peckham-Gregory E, Picarsic J, Prudowsky ZD, Rollins BJ, Shaw PH, Wistinghausen B, Rodriguez-Galindo C, Allen CE; North American Consortium for Histiocytosis. Bielamowicz K, et al. Among authors: rodriguez galindo c. Cancer. 2024 Apr 30. doi: 10.1002/cncr.35301. Online ahead of print. Cancer. 2024. PMID: 38687639 Review.
Identification and characterization of stromal-like cells with CD207+/low CD1a+/low phenotype derived from histiocytic lesions - a perspective in vitro model for drug testing.
Śmieszek A, Marcinkowska K, Małas Z, Sikora M, Kępska M, Nowakowska BA, Deperas M, Smyk M, Rodriguez-Galindo C, Raciborska A. Śmieszek A, et al. Among authors: rodriguez galindo c. BMC Cancer. 2024 Feb 12;24(1):105. doi: 10.1186/s12885-023-11807-0. BMC Cancer. 2024. PMID: 38342891 Free PMC article.
Strategies to promote sustainable care for children with cancer in Ukraine.
Agulnik A, Nogovitsyna Y, Kizyma R, Yakimkova T, Vivtcharenko V, Bhakta N, Wise PH, Rodriguez-Galindo C, Kacharian A. Agulnik A, et al. Among authors: rodriguez galindo c. Lancet Oncol. 2024 Mar;25(3):285-288. doi: 10.1016/S1470-2045(23)00577-6. Epub 2024 Jan 30. Lancet Oncol. 2024. PMID: 38307103 No abstract available.
Understanding treatment recommendations at diagnosis of advanced cancer in pediatric oncology: The need to explore decision-making challenges globally.
Force LM, Hlatywayo L, Salek M, Bhakta M, Bonilla M, Kaye EC, Rodriguez-Galindo C, Baker JN, Bhakta N, Chitsike I. Force LM, et al. Among authors: rodriguez galindo c. Pediatr Blood Cancer. 2024 Apr;71(4):e30854. doi: 10.1002/pbc.30854. Epub 2024 Jan 17. Pediatr Blood Cancer. 2024. PMID: 38233986 No abstract available.
391 results